Spyre Therapeutics, Inc. (SYRE)
92.95
+1.55
(+1.70%)
USD |
NASDAQ |
Oct 21, 16:00
92.94
-0.01
(-0.01%)
After-Hours: 20:00
Spyre Therapeutics Net Income (Annual) : -126.54M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -126.54M |
| December 31, 2024 | -149.56M |
| December 31, 2023 | -94.88M |
| December 31, 2022 | -83.82M |
| December 31, 2021 | -65.80M |
| December 31, 2020 | -80.89M |
| Date | Value |
|---|---|
| December 31, 2019 | -78.25M |
| December 31, 2018 | -44.35M |
| December 31, 2017 | -27.24M |
| December 31, 2016 | -21.70M |
| December 31, 2015 | -11.30M |
| December 31, 2014 | -10.35M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| AbbVie, Inc. | 4.193B |
| Incyte Corp. | 1.287B |
| SELLAS Life Sciences Group, Inc. | -26.86M |
| Relay Therapeutics, Inc. | -276.48M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |